-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on Progyny, Lowers Price Target to $17

Benzinga·11/14/2024 14:06:22
Listen to the news
Barclays analyst Sarah James maintains Progyny (NASDAQ:PGNY) with a Overweight and lowers the price target from $30 to $17.